Anal Carcinoma, Version 2.2012
Al B. Benson, J. Pablo Arnoletti, Tanios Bekaii‐Saab et al. · Journal of the National Comprehensive Cancer Network · 2012
The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.
Cited by 87 works. doi:10.6004/jnccn.2012.0046 Open-access PDF
Authors
- Al B. Benson
- J. Pablo Arnoletti
- Tanios Bekaii‐Saab
- Emily W. Chan
- Yi‐Jen Chen
- Michael A. Choti
- Harry S. Cooper
- Raza A. Dilawari
- Paul F. Engstrom
- Peter C. Enzinger
- Marwan Fakih
- James W. Fleshman
- Charles S. Fuchs
- Jean L. Grem
- Lucille Leong
- Edward H. Lin
- Kilian Salerno May
- Mary F. Mulcahy
- ERIC M. ROHREN
References
- Cancer statistics, 2012
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
- Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
- Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
- Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer
- Sexually Transmitted Infection as a Cause of Anal Cancer
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal